Although initially developed to stratify HCC patients treated with TACE, the HAP score showed that a further improvement of predictive accuracy is possible by combining liver function (albumin, bilirubin) and tumour‐related (AFP, tumour size) parameters.18 The highly comparable SAP score, which adds ECOG PS, performed similarly in our study. The gene discussed is ALB; the disease is hepatocellular carcinoma.